Tissue Regenix Group Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct '25 Oct 21, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	5	43	37	40	38	38
Market Cap Growth	-86.57%	16.73%	-7.68%	5.65%	-0.93%	227.82%
Enterprise Value	12	48	40	41	36	27
Last Close Price	0.07	0.60	0.52	0.56	0.54	0.54
Forward PE	-	250.00	-	-	-	-
PS Ratio	0.25	1.87	1.77	1.95	2.57	3.14
PB Ratio	0.25	1.84	1.59	1.57	1.52	1.35
P/TBV Ratio	0.54	3.20	2.75	2.72	2.53	2.15
P/FCF Ratio	-	-	74.38	-	-	-
P/OCF Ratio	-	-	44.85	-	-	-
EV/Sales Ratio	0.59	2.09	1.95	2.01	2.45	2.21
EV/EBITDA Ratio	27.60	46.40	221.92	-	-	-
EV/EBIT Ratio	-	171.24	-	-	-	-
EV/FCF Ratio	-4.59	-	81.76	-	-	-
Debt / Equity Ratio	0.38	0.36	0.32	0.32	0.24	0.19
Debt / EBITDA Ratio	18.67	7.50	25.88	-	-	-
Debt / FCF Ratio	-	-	14.98	-	-	-
Asset Turnover	0.60	0.65	0.59	0.53	0.41	0.36
Inventory Turnover	1.11	1.23	1.26	1.28	1.17	1.16
Quick Ratio	0.67	0.97	1.72	1.59	2.59	3.76
Current Ratio	2.88	3.46	4.03	3.32	5.06	6.16
Return on Equity (ROE)	-4.94%	-2.92%	-6.28%	-8.14%	-13.91%	-34.70%
Return on Assets (ROA)	-0.63%	0.49%	-0.86%	-2.72%	-5.21%	-5.84%
Return on Invested Capital (ROIC)	-0.73%	0.56%	-0.97%	-3.09%	-5.79%	-6.54%
Return on Capital Employed (ROCE)	-1.20%	0.90%	-1.60%	-5.10%	-9.60%	-9.40%
Earnings Yield	-19.31%	-1.33%	-3.67%	-5.64%	-9.43%	-24.10%
FCF Yield	-50.07%	-9.22%	1.34%	-3.50%	-8.90%	-14.74%
Buyback Yield / Dilution	-1.29%	-0.80%	-0.12%	-0.02%	-58.13%	-279.54%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.